Your browser doesn't support javascript.
loading
Integrating angiogenesis signature and tumor mutation burden for improved patient stratification in immune checkpoint blockade therapy for muscle-invasive bladder cancer.
Shao, Fei; Jin, Kaifeng; Li, Bingyu; Liu, Zhaopei; Zeng, Han; Wang, Yiwei; Zhu, Yu; Xu, Le; Xu, Jiejie; Wang, Zewei; Chang, Yuan; Zhang, Weijuan.
Afiliação
  • Shao F; Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Jin K; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, NHC Key Laboratory of Glycoconjugate Research, Fudan University, Shanghai, China; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li B; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Liu Z; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, NHC Key Laboratory of Glycoconjugate Research, Fudan University, Shanghai, China; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zeng H; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, NHC Key Laboratory of Glycoconjugate Research, Fudan University, Shanghai, China; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang Y; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu L; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu J; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, NHC Key Laboratory of Glycoconjugate Research, Fudan University, Shanghai, China.
  • Wang Z; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: zwwang12@fudan.edu.cn.
  • Chang Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. Electronic address: changyuan0802@163.com.
  • Zhang W; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. Electronic address: weijuanzhang@fudan.edu.cn.
Urol Oncol ; 41(10): 433.e9-433.e18, 2023 10.
Article em En | MEDLINE | ID: mdl-37625906
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China